Table of Content
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.2 Restraint
5.2.3 Opportunity
5.2.4 Challenge
6 Chemoinformatics Market, By Application
6.1 Introduction
6.2 Chemical Analysis
6.2.1 Chemical Databases
6.2.2 Chemo Metrics
6.2.3 Molecular Modelling
6.2.4 Computer Assisted Structure Elucidation
6.2.5 Computer Assisted Synthesis Design
6.3 Drug Discovery
6.3.1 High Throughput Screening
6.3.2 Lead Identification and Optimization
6.3.3 Qsar/Qspr
6.3.4 Adme-Toxicology Prediction
6.4 Drug Validation
6.5 Other Applications
8 Chemoinformatics Market, By Region
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.3 Europe
8.4 Asia Pacific
8.5 Rest of the World
9 Competitive Landscape
9.1 Market Overview
9.2 Market Ranking Analysis, 2018
9.3 Competitive Situation and Trends
9.3.1 Product Launches & Approval
9.3.2 Acquisitions
9.3.3 Agreements
9.3.4 Other Developments
10 Company Profiles
(Business Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments.)*
10.1 Dassault Systemes
10.2 Agilent Technologies
10.3 Bio-Rad Laboratories
10.4 Biosolveit GmbH
10.5 Cerep, Inc.
10.6 Chemaxon, Inc.
10.7 Chemical Computing Group, Inc.
10.8 Jubilant Biosys, Inc.
10.9 Molecular Discovery Ltd.
10.10 Openeye Scientific
*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.
11 Appendix
Growth of the chemoinformatics market is primarily driven by innovations and advancements in the drug development process, advances in the computer technology, increased demand of personalized medicine. On the other hand, cost associated with the chemoinformatics software is one of the major factors restraining the growth of this market. Whereas emerging markets are expected to provide significant growth opportunities in this market.
The report provides an overall understanding of the global chemoinformatics market. This report segments the market on the basis of application and region.
On the basis of applications, the market is segmented into chemical analysis, drug discovery, drug validation, and other applications. On the basis of region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is further divided into US and Canada.
A combination of bottom-up and top-down approaches will be used to calculate the market sizes and growth rates of the global chemoinformatics market and its sub segments. All percentage shares, splits, and breakdowns are determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study will be taken into account, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders will also be used to determine the percentage shares of each sub segment and the relative differences in growth rates.
This research report categorizes the global chemoinformatics market into the following segments and sub segments:
Growth opportunities and latent adjacency in Chemoinformatics Market